📄 Extracted Text (426 words)
SRLI2102 Alpha Group Capital
Polycom: Results Post-Close
2016 Close Acquisition cross Unrealized Returns
Compensation Plans Implemented (Soon) Total Gross MOIC
Strategy & Business Development Fund + Co-Invest 1.9x
• Began implementing new "Ecosystem Fund only:1.9x
Focused" strategy to grow with evolving
Unified Communications market 2.0x • $385 $1,251
• Executed Microsoft partnership agreement
providing for $31 million of engineering $169
support and deeper Go-to-Market
$866 $216 $559
Cost Savings/ EBITDA - Capex Growth
• 2016 PF EBITDA - Capex of $183 mm up from
1.0x $390
$161mm in 2015A
• Achieved $70 mm of run-rate cost savings in
first 4 months of ownership versus target of G
R $692
$90 mm over two years O
Sep-2016 $476
ell. 2017 Repriced Debt S
S Acquisition
• Repriced ld hen debt resulting in 125bps or 0.0s
$11 million savings per year Realized Unrealized Total
M
O ($359) Value Value Value
Cost Savings/ EBITDA - Capex Growth
• 2017 PF EBITDA - Capex of $204 mm I
C
• Achieved $15 mm of run-rate cost savings, ($300)
and identified incremental $30mm of savings
for execution in 2018 (1.0x)
($659)
•• Co-Investor Share
it 2 Sold • Fund Share
Nota ')Cavan informationprovided NavinIn downbod below) relating toot bad m pan on the perfonnanna of
• Plantronics acquired Polycom in a Polycomn pro fontu mforenahon bond on the terms of the sale of the company to Plentromer. Inc. (WISE: PLT).
combination of cash and stock for $2 bn, or Pobrom entered Ito • sale wanner.. with Plantronab Inc. the closed on July 2 2018. pursuant to 'sloth the agreed
upon transaction COIVIdetabOrICOM1411% of apprommately 11.64 babe N cash and O.352 millionshamsof Pientronsca
8.9x 2017 EBITDA of $225 mm commonstock The sate agreement providor for See masonoft he rash consideration smitten millioninvalue dike
Platen.,common stock tole held in avow. Foe purreen arandating the inbred ad unrealised return as of ruin
V. 20lb all of to cash conitderenm. Mochas cash held m escrow lint of a valuation dncoura), dcombed above is
treated a nhdadad and dinnbuted, end the ant earaideration des-reed above is ward a unmelmod. Fraossod
awounts an not expxted to be releand in full end actual mums to SunIll and commttton could be lusthor or tomr
than as de.wn horeuv
Ike alUal Nalaed MUtil d such unrealmni inwalmerd• may differ materially hamlb> MUIm indicated heroin Roan
• Sims see "Aprendix - Footnotes' foe addu tonal coraideretoons end deftnitions Pet performance is not netnitasily indicative
of future results. 24
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0075348
CONFIDENTIAL SDNY_GM_00221532
EFTA01378187
ℹ️ Document Details
SHA-256
514bdeb3b82c22f6b1c22b11a527bf4a1d567f05d8b53aca146fb8ffbfcf63d5
Bates Number
EFTA01378187
Dataset
DataSet-10
Document Type
document
Pages
1
Comments 0